Integrating traditional Chinese medicine and western medicine for cardiovascular disease

Cardiovascular disease is the leading cause of death worldwide. Although coronary artery reperfusion treatment strategies such as thrombolysis and intervention are widely use and successful, the morbidity and mortality of acute myocardial infarction are still high, and it is still the most common cause of heart failure. Biomedical studies focus on the pathophysiology and pathogenesis of coronary heart disease, including atherosclerosis, platelet thrombosis, and immune inflammation. It has identified and revealed new targets and new mechanisms for the onset and development of coronary heart disease. Traditional Chinese medicine and western medicine have their own strengths in the prevention and treatment of coronary heart disease, and can complement each other. In terms of macro-medicine, syndrome differentiation and prevention of disease, and strengthening of the body, “Chinese medicine is the principle and western medicine as practice”. For the microscopic pathophysiology, molecular mechanism, and targeted therapy and other aspects, we can try “western medicine is the principle and Chinese medicine as practice”. Ultimately, improving clinical efficacy is the primary goal, interpreting the scientific connotation of the diagnosis, prevention and treatment of coronary heart disease by Chinese medicine, and improving diagnosis and treatment innovations such as early diagnosis, general treatment and differentiation treatment for coronary heart disease with the combined use of Chinese and western medicine.